Trading resume tomorrow.. But will be suspended next Wednesday.

Solid cash flow.

JAKARTA (Sept 26): Malaysian palm oil futures fell nearly 7% on Monday (Sept 26), tracking weakness in rival edible oils amid recession fears, and after a leading analyst warned prices would plunge by more than 30% by the end of this year due to ample supply and weaker demand.

The benchmark palm oil contract for December delivery on the Bursa Malaysia Derivatives Exchange dropped 6.85% to trade at RM3,480 a tonne in early session, down for a third straight session.

PETALING JAYA: Putrajaya will be making a decision “very soon” on proposals for an extension to the sales and service tax (SST) for new vehicle orders, says transport minister Wee Ka Siong.

Good news.

Value trap stock.

Good luck guys.. Sold off. Get something better than nothing.

A value trap is a stock or other investment that appears to be cheaply priced because it has been trading at low valuation metrics, such as multiples in terms of price to earnings (P/E), price to cash flow (P/CF), or price to book value (P/B) for an extended time period.

Value trap

It will go below 0.10

Likely to go down to 0.12, similar to other companies who called for right issue.

a. The suspension of trading of SCIB’s securities will be effected on the next market day after the expiry of 5 market days from 31 October 2021.

 

b. The date of suspension of trading will be on 9 November

KUALA LUMPUR (Aug 12): Pharmaniaga Bhd said today it has secured an acceptance letter, Surat Setuju Terima (Tambahan) or SST, from the Ministry of Health (MoH) for the purchase of an additional six million doses of Sinovac Covid-19 vaccine (Coronavac Suspension for Injection).

Pharmaniaga Bhd said today nearly half of the 14 million Sinovac vaccine doses it plans to sell from next month have been ordered by various state governments running initiatives parallel to the National Covid-19 Immunisation Programme (NIP).

KUALA LUMPUR (July 16): Malaysia will hold bilateral talks with Thailand to seek assurances there will be no disruption to the supply of AstraZeneca vaccines manufactured in its Southeast Asian neighbour, a Malaysian minister said on Friday.

Malaysia will also consider ramping up the supply of vaccines developed by China's Sinovac if there are shortages of the AstraZeneca vaccine, Science Minister Khairy Jamaluddin told a news conference.

Malaysia is not discontinuing the use of the Sinovac vaccine, its local licence holder Pharmaniaga Bhd said, adding that the remaining supply of the vaccine is being saved for recipients who have yet to get their second doses.

In a statement today, the company said it wanted to clarify and correct some news reports which claimed that the government is ending the use of the Sinovac vaccine in its national immunisation

Malaysia will increasingly use the Pfizer-BioNTech mRNA vaccines, Minister Adham Baba told a news conference. The Southeast Asian country secured 12 million doses of the Sinovac vaccine so far, enough to cover 18.75% of the population.

KUALA LUMPUR (July 15): Malaysia's health minister on Thursday said the country will stop administering the Covid-19 vaccine produced by China's Sinovac once its supplies end, as it has a sufficient number of other vaccines for its programme.

Each RCUIDS will be priced at a nominal value of 75 sen apiece. The RCUIDS come with a seven-year tenure and a profit rate of 8% per year. Each RCUIDS are also convertible to one new AirAsia share on a one-to-one basis, according to the filing to Bursa Malaysia.

AAGB (“Board”), RHB Investment Bank Berhad wishes to announce that the Company proposes to undertake a renounceable rights issue of up to RM1,024,058,370 in nominal value of 7-year redeemable convertible unsecured Islamic debt securities with a nominal value of RM0.75 each (“RCUIDS”) on the basis of 2 RCUIDS with 1 free detachable warrant for every 6 ordinary shares in AAGB held on an entitlement date to be determined by the Board and announced later by the Company (“Proposed Rights Issue”).

KUALA LUMPUR/BANGKOK (July 7): Malaysia's low-cost airline AirAsia Group Bhd is considering a listing of its digital arm via a special-purpose acquisition company (SPAC) in the United States to raise at least US$300 million, its chief said on Wednesday.

KUALA LUMPUR (July 1): AirAsia Group Bhd’s e-wallet unit Big Pay is partnering Malaysian Industrial Development Finance Bhd (MIDF) in a consortium to apply for Malaysia’s digital banking licence.

National regulatory authorities have granted emergency use authorizations for sixteen COVID-19 vaccines. Five of those have been approved for emergency or full use by at least one WHO-recognized stringent regulatory authority (Oxford–AstraZeneca, Pfizer-BioNTech, Sinopharm-BBIBP, Moderna, Sinovac, and Johnson

WHO approves Sinovac BIOTECH's corona virus for emergency use, the second Chinese treatment to win designation.

KUALA LUMPUR (May 24): KNM Group Bhd has proposed a private placement of up to 987.52 million new shares, representing 30% of its share capital, to raise RM167.9 million in proceeds for the purpose of repaying its bank borrowings.

I work for a procurement company, at this moment, global supply of petrol chemicals is very tight due to shortage of supply.

Tight supply of petrol chemical now.

Back to Felda gangs to manage FGV.

KUALA LUMPUR (March 17): Bank Negara Malaysia (BNM) has announced an additional allocation of RM700 million for the SME Automation and Digitalisation Facility (ADF), bringing the facility’s total allocation to RM1 billion.

Warren Buffett once said that it is wise for investors to be “fearful when others are greedy, and greedy when others are fearful.”

80.99%..privatisation fail.

From the Star business news.

TECHNOLOGY stocks may be taking a breather but that does not seem to be stopping a decent flow of new listings from this sector.

Yesterday, a company that makes Internet of Things (IoT)-based products got listed on the Singapore Stock Exchange with a market value of just under S$1bil (RM3.7bil).

The Singapore firm, with one of its operations in Johor, had attracted some Malaysian funds as cornerstone investors. These included the likes of the Employees Provident Fund, Affin Hwang Asset Management and Hong Long Assurance.

RTHK has learned that a third person has died in Hong Kong after taking the mainland-produced Sinovac vaccine – 10 days after the territory-wide inoculation programme was rolled out here.

The Board wishes to announce that the Board had on 25 February 2021 received a notice from Maybank Investment Bank Berhad, on behalf of the Offeror, informing that the closing date and time for the acceptance of the Offer have been further extended from 5.00 p.m. (Malaysian time) on Tuesday, 2 March 2021 to 5.00 p.m. (Malaysian time) on Monday, 15 March 2021 (“Final Closing Date”). Save for the Final Closing Date, all other details and terms and conditions of the Offer as set out in the Offer Document remain unchanged.

Abdul Wahid bin Omar is the non-executive chairman of Bursa Malaysia since 1 May 2020.

Tan Sri Abdul Wahid Omar, chairman of the special task force on Felda

Bursa said that for companies with a market capitalisation of at least RM1 billion but less than RM3 billion, the acceptable minimum lower public shareholding spread is 20%.

For companies with a market capitalisation of RM3 billion and above, the acceptable minimum lower public shareholding spread is 15%, according to Bursa.

Bursa said that under its public spread amendments, which will take effect from Monday (March 1, 2021), the quantitative and qualitative criteria include "the appropriateness and rationale of the application, including if there is sufficiency of liquidity, orderliness of trading of the securities, good corporate governance conduct and compliance records of the listed issuer/applicant and its directors, as well as reasonable justification necessitating the lower public spread".

That's the reason why it is still lagging behind.

FYI.

Uchitech is listed in Bursa as industrial products and services sector.

For sharing.

1. 33% - threshold for triggering the mandatory offer;

2. Over 50% - a mandatory offer ceases to be conditional;

3. 75% - holder can ensure special resolutions are passed;

4. Over 75% - the minimum public floating required for companies listed on the stock exchange may not be satisfied;

5. 90% - generally, confers the ability to compulsorily acquire the remaining shares in the target company;

6. 90% - trading of the shares may be suspended by the stock exchange. The shares may also be de-listed by the stock exchange.

For sharing:

If more than 75% but less than 90% of the FGV shares are held by the offeror and the person acting in concert with him pursuant to offer, the offeror will not be taking steps to address any shortfall in the Public Spread Requirement and request FGV to make the necessary application to withdraw its listing status from the official list via a general meeting to be convened to obtain approval from the majority shareholders of FGV in accordance with Paragraph 16.06 of the Listing Requirement.